ERBB2 and neoplasm: The ILC patients, in comparison to IDC patients, were found to be older, have more advanced tumor stage, larger tumor size, higher incidence of axillary lymph node metastasis, greater positivity of ER and PR receptors, lower incidence of HER2 positivity, and were less likely to receive chemotherapy (P < 0.001 for all variables).